|
NOLC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.34620000000496E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.901540E-03 |
| Normal-vs-Stage2 |
1.620210E-03 |
| Normal-vs-Stage3 |
1.99550000001825E-06 |
| Normal-vs-Stage4 |
1.610890E-04 |
| Stage1-vs-Stage2 |
3.184200E-01 |
| Stage1-vs-Stage3 |
6.756900E-03 |
| Stage1-vs-Stage4 |
1.026360E-01 |
| Stage2-vs-Stage3 |
3.640200E-01 |
| Stage2-vs-Stage4 |
7.414200E-01 |
| Stage3-vs-Stage4 |
5.299800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.35739999999707E-05 |
| Normal-vs-AfricanAmerican |
8.756700E-03 |
| Normal-vs-Asian |
3.122400E-01 |
| Caucasian-vs-AfricanAmerican |
8.052000E-01 |
| Caucasian-vs-Asian |
5.902200E-01 |
| AfricanAmerican-vs-Asian |
7.182400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.10769999994709E-06 |
| Normal-vs-Female |
1.169620E-02 |
| Male-vs-Female |
5.421900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.864000E-02 |
| Normal-vs-Age(41-60Yrs) |
6.29309999999883E-05 |
| Normal-vs-Age(61-80Yrs) |
3.416300E-04 |
| Normal-vs-Age(81-100Yrs) |
2.236400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.006400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.854800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.860400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.466600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.378960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.267230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.242600E-01 |
| Normal-vs-Grade 2 |
6.276400E-03 |
| Normal-vs-Grade 3 |
2.20849999954531E-07 |
| Normal-vs-Grade 4 |
1.623620E-04 |
| Grade 1-vs-Grade 2 |
1.616350E-01 |
| Grade 1-vs-Grade 3 |
1.101890E-02 |
| Grade 1-vs-Grade 4 |
4.299800E-02 |
| Grade 2-vs-Grade 3 |
5.391100E-04 |
| Grade 2-vs-Grade 4 |
4.088200E-02 |
| Grade 3-vs-Grade 4 |
6.768600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.415600E-03 |
| Normal-vs-ccB subtype |
4.42919999998903E-06 |
| ccA subtype-vs-ccB subtype |
9.723800E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.75769999999753E-05 |
| Normal-vs-N1 |
4.639800E-01 |
| N0-vs-N1 |
2.625600E-01 |
|
|
